Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-10-25 Sale |
2022-10-27 6:00 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,588 | $4.4 | $6,987 | 139,354 (Direct) |
View |
| 2022-09-23 Sale |
2022-09-27 7:00 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,741 | $3.07 | $5,345 | 140,942 (Direct) |
View |
| 2022-08-24 Sale |
2022-08-26 7:01 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,652 | $3.71 | $6,129 | 142,683 (Direct) |
View |
| 2022-07-25 Sale |
2022-07-27 9:02 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,686 | $4.33 | $7,300 | 144,335 (Direct) |
View |
| 2022-06-23 Sale |
2022-06-27 7:00 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,635 | $4.34 | $7,096 | 146,021 (Direct) |
View |
| 2022-05-20 Sale |
2022-05-24 7:00 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
12,127 | $3.7 | $44,870 | 147,656 (Direct) |
View |
| 2022-04-25 Sale |
2022-04-27 7:00 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
703 | $3.84 | $2,700 | 159,783 (Direct) |
View |
| 2022-03-30 Sale |
2022-04-01 6:00 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
2,486 | $4.84 | $12,032 | 160,486 (Direct) |
View |
| 2022-03-25 Sale |
2022-03-29 6:27 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
7,281 | $5.06 | $36,842 | 165,049 (Direct) |
View |
| 2022-03-18 Sale |
2022-03-22 9:00 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
2,153 | $5.13 | $11,045 | 172,330 (Direct) |
View |
| 2022-03-07 Sale |
2022-03-09 9:45 pm |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
3,091 | $5.52 | $17,062 | 174,483 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-11-20 Other |
2022-11-22 6:33 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,584 | $5 | 139,354 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-21 9:11 pm |
N/A 2032-06-12 |
NeuroPace Inc | NPCE | Kumar Rakhi Director |
18,253 | $0 | 18,253 (Direct) |
View |
| 2022-04-20 Option Award |
2022-04-22 7:29 pm |
N/A 2032-04-19 |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
1,000,000 | $0 | 1,000,000 (Direct) |
View |
| 2022-03-30 Tax Withholding |
2022-04-01 6:00 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
2,077 | $4.74 | 160,486 (Direct) |
View |
| 2021-04-21 Option Award |
2021-10-08 6:16 pm |
N/A 2031-04-20 |
NeuroPace Inc | NPCE | Kumar Rakhi Director |
21,698 | $0 | 21,698 (Direct) |
View |
Ownership |
2021-10-01 5:47 pm |
N/A N/A |
Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer |
0 | $0 | 984,440 (Direct) |
View |